H.B. No. 1379
 
AN ACT
relating to human papillomavirus education programs.
       BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
       SECTION 1.  Subchapter A, Chapter 161, Health and Safety
Code, is amended by adding Section 161.0107 to read as follows:
       Sec. 161.0107.  HUMAN PAPILLOMAVIRUS; VACCINES EDUCATION
MATERIALS.  (a)  The department, using existing resources, shall
produce and distribute informational materials regarding vaccines
against human papillomavirus that are approved by the United States
Food and Drug Administration for human use.  The materials must
include information relating to the effectiveness, availability,
and contraindications of the vaccines. The materials must be
available in English and in Spanish.
       (b)  The department shall collaborate with the Texas Cancer
Council or its successor entity to develop educational programs for
parents regarding human papillomavirus and promoting awareness of a
minor's need for preventive services for cervical cancer and its
precursors.
       (c)  The department shall develop and maintain an Internet
website that targets the public and health care professionals and
provides accurate, comprehensive information on all aspects of
cervical cancer prevention, including vaccination against human
papillomavirus.
       SECTION 2.  Chapter 163, Health and Safety Code, is amended
by adding Section 163.003 to read as follows:
       Sec. 163.003.  ADDITIONAL INSTRUCTIONAL ELEMENTS REGARDING
HUMAN PAPILLOMAVIRUS.  Course materials and instruction relating to
sexually transmitted diseases must be available in English and in
Spanish and should include:
             (1)  the following specific information on human
papillomavirus:
                   (A)  that sexual intercourse is not required to
become infected with human papillomavirus and that the avoidance of
skin-to-skin contact involving the genital areas offers the best
protection;
                   (B)  that both males and females may be infected
with human papillomavirus and symptoms may not be present;
                   (C)  that younger women are at greater risk of
human papillomavirus infection than older women; and
                   (D)  that human papillomavirus may be transmitted
to an infant during childbirth;
             (2)  information regarding the role of human
papillomavirus in the development of genital warts, cervical
cancer, and other diseases; and
             (3)  information regarding the continuing need for
women to undergo Pap smear testing, even if they have received a
vaccination against human papillomavirus.
       SECTION 3.  This Act takes effect September 1, 2007.
____________________________________________________________
   President of the SenateSpeaker of the House      
       I certify that H.B. No. 1379 was passed by the House on March
15, 2007, by the following vote:  Yeas 140, Nays 3, 2 present, not
voting; and that the House concurred in Senate amendments to H.B.
No. 1379 on May 1, 2007, by the following vote:  Yeas 144, Nays 0, 2
present, not voting.
______________________________
Chief Clerk of the House   
       I certify that H.B. No. 1379 was passed by the Senate, with
       I certify that H.B. No. 1379 was passed by the Senate, with
amendments, on April 26, 2007, by the following vote:  Yeas 31,
Nays 0.
______________________________
Secretary of the Senate   
APPROVED: __________________
APPROVED: __________________
                Date       
 
 
         __________________
              Governor